AAAAAA

   
Results: 1-8 |
Results: 8
CARCINOEMBRYONIC ANTIGEN IN MONITORING THE GROWTH OF HUMAN COLON ADENOCARCINOMA TUMOR-CELLS SK-CO-1 AND HT-29 IN-VITRO AND IN NUDE-MICE
Authors: SOLETORMOS G FOGH JM SEHESTEDHANSEN B SPANGTHOMSEN M SCHIOLER V DOMBERNOWSKY P SKOVSGAARD T
Citation: G. Soletormos et al., CARCINOEMBRYONIC ANTIGEN IN MONITORING THE GROWTH OF HUMAN COLON ADENOCARCINOMA TUMOR-CELLS SK-CO-1 AND HT-29 IN-VITRO AND IN NUDE-MICE, European journal of cancer, 33(1), 1997, pp. 108-114
TUMOR-MARKERS CANCER ANTIGEN-15.3, CARCINOEMBRYONIC ANTIGEN, AND TISSUE POLYPEPTIDE ANTIGEN FOR MONITORING METASTATIC BREAST-CANCER DURING FIRST-LINE CHEMOTHERAPY AND FOLLOW-UP
Authors: SOLETORMOS G NIELSEN D SCHIOLER V SKOVSGAARD T DOMBERNOWSKY P
Citation: G. Soletormos et al., TUMOR-MARKERS CANCER ANTIGEN-15.3, CARCINOEMBRYONIC ANTIGEN, AND TISSUE POLYPEPTIDE ANTIGEN FOR MONITORING METASTATIC BREAST-CANCER DURING FIRST-LINE CHEMOTHERAPY AND FOLLOW-UP, Clinical chemistry, 42(4), 1996, pp. 564-575
TUMOR-MARKERS IN THE MANAGEMENT OF PATIENTS WITH OVARIAN-CANCER
Authors: TUXEN MK SOLETORMOS G DOMBERNOWSKY P
Citation: Mk. Tuxen et al., TUMOR-MARKERS IN THE MANAGEMENT OF PATIENTS WITH OVARIAN-CANCER, Cancer treatment reviews, 21(3), 1995, pp. 215-245
A NOVEL METHOD FOR MONITORING HIGH-RISK BREAST-CANCER WITH TUMOR-MARKERS - CA-15.3 COMPARED TO CEA AND TPA
Authors: SOLETORMOS G NIELSEN D SCHIOLER V SKOVSGAARD T WINKEL P MOURIDSEN HT DOMBERNOWSKY P
Citation: G. Soletormos et al., A NOVEL METHOD FOR MONITORING HIGH-RISK BREAST-CANCER WITH TUMOR-MARKERS - CA-15.3 COMPARED TO CEA AND TPA, Annals of oncology, 4(10), 1993, pp. 861-869
PROGNOSTIC VALUE OF SERUM TETRANECTIN IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: HOGDALL CK SOLETORMOS G NIELSEN D NORGAARDPEDERSEN B DOMBERNOWSKY P CLEMMENSEN I
Citation: Ck. Hogdall et al., PROGNOSTIC VALUE OF SERUM TETRANECTIN IN PATIENTS WITH METASTATIC BREAST-CANCER, Acta oncologica, 32(6), 1993, pp. 631-636
THE DIAGNOSTIC AND PROGNOSTIC VALUE OF SERUM BONE GLA PROTEIN (OSTEOCALCIN) IN PATIENTS WITH RECURRENT BREAST-CANCER
Authors: KAMBY C EGSMOSE C SOLETORMOS G DOMBERNOWSKY P
Citation: C. Kamby et al., THE DIAGNOSTIC AND PROGNOSTIC VALUE OF SERUM BONE GLA PROTEIN (OSTEOCALCIN) IN PATIENTS WITH RECURRENT BREAST-CANCER, Scandinavian journal of clinical & laboratory investigation, 53(5), 1993, pp. 439-446
INTERPRETATION OF RESULTS FOR TUMOR-MARKERS ON THE BASIS OF ANALYTICAL IMPRECISION AND BIOLOGICAL VARIATION
Authors: SOLETORMOS G SCHIOLER V NIELSEN D SKOVSGAARD T DOMBERNOWSKY P
Citation: G. Soletormos et al., INTERPRETATION OF RESULTS FOR TUMOR-MARKERS ON THE BASIS OF ANALYTICAL IMPRECISION AND BIOLOGICAL VARIATION, Clinical chemistry, 39(10), 1993, pp. 2077-2083
DIAGNOSTIC-VALUE OF CEREBROSPINAL-FLUID CYTOLOGY IN COMPARISON WITH TUMOR-MARKER ACTIVITY IN CENTRAL-NERVOUS-SYSTEM METASTASES SECONDARY TOBREAST-CANCER
Authors: BACH F BJERREGAARD B SOLETORMOS G BACH FW HORN T
Citation: F. Bach et al., DIAGNOSTIC-VALUE OF CEREBROSPINAL-FLUID CYTOLOGY IN COMPARISON WITH TUMOR-MARKER ACTIVITY IN CENTRAL-NERVOUS-SYSTEM METASTASES SECONDARY TOBREAST-CANCER, Cancer, 72(8), 1993, pp. 2376-2382
Risultati: 1-8 |